background
vernal
keratoconjunct
vkc
common
eye
diseas
result
perman
decreas
loss
vision
houttuynia
eye
drop
hed
use
treatment
vkc
howev
clinic
evid
hed
well
conclud
herein
describ
propos
system
review
metaanalysi
evalu
clinic
efficaci
hed
treatment
vkc
method
six
electron
databas
medlin
embas
cochran
databas
chines
nation
knowledg
infrastructur
wanfang
databas
chines
biolog
medicin
databas
search
random
control
trial
rct
evalu
clinic
efficaci
hed
treatment
vkc
studi
meet
elig
criteria
includ
data
includ
studi
extract
qualiti
also
evalu
data
synthesi
perform
use
revman
softwar
sensit
analysi
public
bia
also
investig
result
studi
provid
highqual
system
review
synthesi
rct
efficaci
hed
treatment
vkc
conclus
system
review
metaanalysi
conclud
efficaci
hed
treatment
vkc
abbrevi
cbm
chines
biolog
medicin
databas
ci
confidenti
interv
cnki
chines
nation
knowledg
infrastructur
hed
houttuynia
eye
drop
rct
random
control
trial
vkc
vernal
keratoconjunct
vernal
keratoconjunct
vkc
bilater
chronic
sightthreaten
ocular
diseas
usual
occur
patient
year
age
vkc
wide
geograph
distribut
commonli
found
warm
dri
area
patient
vkc
usual
present
eye
irrit
itch
red
tear
pain
blur
vision
etiolog
vkc
still
unclear
allerg
mechan
thought
involv
pathogenesi
diseas
vkc
result
perman
decreas
loss
vision
treatment
fail
achiev
good
treatment
outcom
long
durat
drug
treatment
combin
live
habit
adjust
need
numer
topic
drug
use
vkc
treatment
vasoconstrictor
mastcel
stabil
antihistamin
nonsteroid
antiinflammatori
agent
corticosteroid
immunomodul
drug
reduc
sign
symptom
acut
phase
vkc
therapeut
result
satisfi
recent
herbal
medicin
becom
altern
therapi
number
diseas
houttuynia
tradit
chines
herb
primarili
found
china
japan
korea
southeast
asia
use
treatment
variou
diseas
hundr
year
main
activ
compon
houttuynia
flavonoid
flavonoid
glycosid
ionon
alkaloid
houttuynia
extract
prove
antibacteri
antiallerg
antiinflammatori
antioxid
effect
report
houttuynia
eye
drop
hed
achiev
good
effect
treatment
vkc
howev
system
review
metaanalysi
publish
regard
clinic
efficaci
hed
plan
run
system
review
metaanalysi
random
control
trial
rct
assess
efficaci
hed
treatment
vkc
protocol
written
follow
prefer
report
item
system
review
meta
analysi
protocol
prismap
statement
protocol
regist
prospero
ethic
approv
need
research
involv
publish
data
elig
criteria
type
studi
rct
includ
studi
studi
patient
concomit
ocular
diseas
exclud
studi
enrol
patient
also
exclud
patient
treat
hed
alon
combin
drug
restrict
regard
dose
frequenc
durat
administ
drug
patient
treat
drug
intervent
group
hed
patient
treat
treat
placebo
also
includ
restrict
regard
publish
languag
follow
databas
search
electron
medlin
embas
cochran
databas
chines
nation
knowledg
infrastructur
cnki
wanfang
databas
chines
biolog
medicin
databas
cbm
electron
databas
search
use
combin
follow
item
houttuynia
herba
houttuynia
houttuynia
cordata
houttuynia
cordata
thunb
heartleaf
houttuynia
herb
houttuynia
extract
eyedrop
eye
drop
gutta
vkc
combin
search
item
adjust
suit
search
databas
relev
literatur
refer
includ
studi
search
manual
literatur
search
review
lyy
xyc
independ
result
cross
check
discrep
solv
third
review
zwi
yield
studi
manag
use
refer
manag
softwar
name
noteexpress
aegean
technolog
beij
china
two
review
lyy
xyc
review
titl
andor
abstract
studi
select
studi
accord
elig
criteria
independ
full
text
search
studi
review
need
discrep
solv
review
zwi
follow
item
includ
studi
collect
author
publish
year
studi
area
durat
patient
characterist
gender
age
baselin
symptom
dose
treatment
durat
hed
experiment
group
coadminist
drug
experiment
group
exist
therapi
control
group
outcom
requir
item
publish
origin
studi
review
zwi
contact
origin
author
miss
data
email
collect
data
manag
use
electron
tabl
collect
done
review
lyy
xyc
independ
discrep
solv
review
zwi
outcom
main
outcom
main
outcom
system
review
metaanalysi
clinic
respons
rate
clinic
respons
defin
cure
obvious
remiss
symptom
itch
tear
photophobia
ropi
mucou
discharg
foreign
bodi
sensat
sign
conjunctiv
hyperemia
epitheli
punctat
kerat
tranta
dot
limbal
edema
palpebr
conjunctiv
giant
papilla
vkc
chang
score
symptom
cure
rate
remiss
rate
remiss
rate
consid
cure
rate
risk
bia
individu
studi
assess
use
cochran
risk
bia
tool
follow
item
evalu
random
sequenc
gener
alloc
conceal
blind
particip
research
incomplet
outcom
data
select
report
bia
bia
item
categor
low
risk
unclear
high
risk
includ
studi
categor
low
risk
item
categor
low
risk
includ
studi
categor
high
risk
one
item
categor
high
risk
studi
categor
unclear
assess
done
review
lyy
xyc
independ
discrep
solv
review
zwi
data
synthesi
carri
revman
softwar
version
copenhagen
nordic
cochran
center
cochran
collabor
heterogen
among
studi
evalu
use
test
data
synthesi
odd
ratio
valu
confidenti
interv
ci
calcul
categor
outcom
clinic
respons
rate
cure
rate
mean
differ
ci
calcul
chang
score
symptom
mantelhaenszel
fixedeffect
model
use
calcul
otherwis
random
effect
model
use
subgroup
analysi
run
includ
studi
suffici
analysi
carri
base
follow
item
type
combin
therapi
sever
diseas
sensit
analysi
run
use
leaveoneout
method
briefli
main
outcom
evalu
exclud
studi
one
one
robust
synthes
result
evalu
public
bia
evalu
use
funnel
plot
includ
studi
main
outcom
summar
use
grade
recommend
assess
develop
evalu
approach
discuss
protocol
present
methodolog
system
review
metaanalysi
rct
evalu
efficaci
hed
treatment
vkc
propos
system
review
metaanalysi
run
report
accord
prisma
guidelin
provid
high
level
evid
valu
hed
therapi
time
major
limit
credibl
system
review
metaanalysi
affect
qualiti
includ
studi
foreseen
studi
high
risk
bia
includ
